Comparison of the Effect of High-Dose Steroid with That of Super-High-Dose Steroid Therapy in Sudden Sensorineural Hearing Loss.
10.3342/kjorl-hns.2009.52.7.566
- Author:
Hyun Ho PARK
1
;
Jae Hyeok CHOI
;
Eun Jeong HUH
;
Tae Hoon LEE
;
Jung Kwon NAM
;
Joong Keun KWON
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea. kwonmail@hanafos.com
- Publication Type:Original Article
- Keywords:
Sudden hearing loss;
Steroids
- MeSH:
Adrenal Cortex Hormones;
Ear, Inner;
Hearing;
Hearing Loss, Sensorineural;
Hearing Loss, Sudden;
Humans;
Hydrocortisone;
Prednisolone;
Steroids
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2009;52(7):566-571
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Corticosteroids have been used for therapeutic management of sudden sensorineural hearing loss (SSNHL). Because the levels of steroid within inner ear after systemic administration is very low, high-dose steroid regimens have been used. The purpose of this study is to compare the effect of high-dose (HD) steroid therapy with that of super-highdose (SHD) steroid therapy in SSNHL. SUBJECTS AND METHOD: The study group consisted of 97 patients diagnosed as SSNHL. They were divided into two groups : those who were administered 60 mg prednisolone as the initial high dose (HD group) and those who were administered 1,200 mg hydrocortisone (about 300 mg prednisone) as the super high dose (SHD group). RESULTS: Hearing improvement was observed in 76.8% of HD group and in 67.9% of SHD group and there was no statistically significant difference in the rate of hearing improvement between HD group and SHD group. CONCLUSION: Super-high-dose steroid regimen is not superior to high-dose steroid regimen in the treatment of SSNHL.
